Member Info for Latino

My main point was not about Mighty (yes he should also add) but about Keith Sadler who as the IC, has bought zero shares from what I see, after all he’s oversaw the sale and has tailored the new strategy so must have confidence in it to now start buying..

Think BoD need to show confidence to the market and should be buying here big..at these absolute basement level prices! For instance, Keith Sadler (Interim Chairman) has never bought any shares here, and he’s the Chairman!

Start buying and show market confidence! This includes Mr Mighty and the rest.

Never seen a cash shell company with a cash burn like this on ‘transaction related expenses’ and ‘due diligence’. Blowing mega £24.1M in the process and securing zero acquisition. Now £0.9M left, and even that includes any tax refunds!

Yes, and we now have the mad derampers causing the drop lol

Also no need to twist the words with ‘maybe they meant’, we all know the game you’re playing and we can all read in English! Therefore no need to insult the intelligence of investors.

Just like when it bounced to 3.4p...sure you must have though the same thing then lol

Watch and learn!!

Ready to bounce very soon?...MMs have literally flushed the weak holders here.

‘Hard to sell’ bet people said this the last time also lol The fact is that this is now closer to approval than its ever been.

What non-sensical nonsense are you posting lol We knew this already so this is nothing new, read 30th/2nd RNS...so this is already priced in, it’s exactly what the CEO told us then..the fear here was FDA muddling this or adding to this..

Frankly speaking, here no news is excellent news considering how FDA have screwed this company over with ambiguity and dithering on their decision.

So, as the bod indicated the potential interested parties now know exactly what they want and how to get there (approval route). This removes the uncertainty, which any interested party would have wanted confirmation on before making their move..

Yes dump crew will be disappointed with this...bet they were banking on more surprises and additional trial work!

What we’re the derampers expecting..an additional trial!

Perhaps previous 3.4p bid would still be very cheap, if they secure a profitable / cash generative acquisition. Perhaps Mr Market will factor in the possibility/probability of this..and strong BOD experiences and knowledge also to secure such rto....time to re-rate!

As I've said for weeks - don't be last out IMVHO.

For those of you who haven’t seen the new website:
http://hawkwing.co/investor/shareholder-information/strategy/

Bargain basement to me, can’t believe they’ve let it drop this far! Could do with some BOD buys here..

That is why I strongly believe (like the company) and there was enough there with the 600 trial to grant marketing approval with requirements to undertake post-approval trial within say next 12months + labelling changes to warn of these risks. BUT they decided not to...and Lille we’re saying if this was a large pharma the decision would have been different!

Maybe it’s time now this CEO steps down, SP bashed to lowest ever for weeks now, and not even a single word! Needs to step down or start properly updating and communicating with its investors.

Just to expand on this point. We had over $12.3M in cash and $15M Hercules Loan (3M deficit) at 31st Dec 18.

Through the year; paid Hercules 7.5M and raised 3.3M, leaving approx 8M cash and 6.9M debt to Hercules.

So one can argue, the FDA farsic has cost the company approx $8M or say after expenses a good $7M! That is absolutely outrageous!

Now in Oct

Now

At 31 December 2018, the Company had cash of $12.3 million and $15 million of debt drawn from its Hercules loan facility. The Company is financed into the second quarter of 2019 but will need to raise capital in the near term

Remember SP rose over 3p just on future strategy announcement in EGM Notice. BoD working on a business ‘profitable and cash generative’ since June 19. So, once the news starts coming in there will be no chance to buy at these ridiculously bargain prices..gla

Offer/bid equal now..

From June, but just a reminder of the results and potential market for Iclaprim.
http://ir.motifbio.com/static-files/59d7f601-0361-4e1c-a573-d8cbe742bdd0